Metraipolis › archive › dc_25ab77cc6cfc

Targeted Cepharanthine-Mediated Dual-Pathway Inhibition Sensitizes Pancreatic Cancer to Gemcitabine — Europe PMC PMID:42795423

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42795423
DOI
10.3390/life16091560
License (as archived)
solo-consultazione
Archived
2026-10-08T07:47:35.895Z
SHA-256 of the archived text
be1adb4538859b02b0307b51b8c93284bafb2f0bbda3d0b8af377f3a03cabd55
Stable URL of this page
https://metraipolis.com/documento/dc_25ab77cc6cfc

How to cite

Targeted Cepharanthine-Mediated Dual-Pathway Inhibition Sensitizes Pancreatic Cancer to Gemcitabine — Europe PMC PMID:42795423 — Europe PMC (en), https://europepmc.org/article/MED/42795423 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_25ab77cc6cfc (Metraipolis archive dc_25ab77cc6cfc, sha256 be1adb4538859b02b0307b51b8c93284bafb2f0bbda3d0b8af377f3a03cabd55)
BibTeX
@misc{dc25ab77cc6cfc,
  title = {Targeted Cepharanthine-Mediated Dual-Pathway Inhibition Sensitizes Pancreatic Cancer to Gemcitabine — Europe PMC PMID:42795423},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42795423},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_25ab77cc6cfc; sha256 be1adb4538859b02b0307b51b8c93284bafb2f0bbda3d0b8af377f3a03cabd55},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42795423. Agents can read the archived copy with the MCP tool read_document.